Acción Icad (ICAD)
Empresa del sector salud. Aquí tienes el precio, un resumen del negocio y lo que conviene saber sobre Icad en septiembre 2026.
iCAD, Inc. provides artificial intelligence-powered cancer detection. Its ProFound Breast Health Suite enables medical providers and professionals to accurately and reliably identify where cancer may be hiding. Its Cancer Detection segment solutions include advanced artificial intelligence and image analysis workflow solutions that enable healthcare professionals to serve patients by identifying pathologies and pinpointing the prevalent cancers earlier, a range of upgradeable computer-aided detection systems and workflow solutions for digital breast tomosynthesis, full-field digital mammography, magnetic resonance imaging and computed tomography. ProFound Suite offers 360-degree solutions for cancer detection, density assessment, and personalized risk evaluation, all based on a two-dimensional or three-dimensional mammogram’s collection of images. ProFound Density Assessment standardizes and simplifies breast density reporting and algorithmically examining.
Sobre esta acción
ICAD INC
ICAD
Precio actual
$3.84
Beneficio potencial a 12 meses
13.93%
Sector
Salud
Industria
Equipos y suministros sanitarios
Símbolo
ICAD
Capitalización de mercado
$106.31M
Beneficio potencial a 12 meses
13.93%
Sector
Salud
Industria
Equipos y suministros sanitarios
Rendimiento del crecimiento a seis meses
Resumen del rendimiento de la acción
Calificación de los analistas
Analysts suggest holding ICAD's stock with a target price of $4.38, indicating potential growth.
Salud financiera
ICAD INC shows strong revenue and profit margins, with solid cash flow per share indicating financial stability.
Ve más acciones descargando la app GRATIS
Solo toma 60 segundos.
¿Por qué invertir con Nemo?
Cero comisiones
Opera acciones, ETF y más sin comisiones. Conserva una mayor parte de tus ganancias.
Confiable y regulado
Parte del grupo Exinity desde 2015, con más de un millón de clientes en todo el mundo.